Provisional findings hint that Covaxin may generate antibodies that may persist for 6-12 mths Results have not yet undergone peer review, findings are provisional, and the conclusions/final results may differ
3 Indian vaccines in phase-2 has created Apollo 11 moment for India: Dr V K Paul No pressure on regulators for approval of the vaccine, final call on allowing emergency use approval will be made on scientific…
India’s first COVID-19 vaccine by Bharat Biotech’s gets DCGI approval for human clinical… COVAXIN has been developed in collaboration with ICMR and National Institute of Virology Bharat Biotech has developed…
